ConductScience.org, home

Paper32397643

Potential Drugs Targeting Early Innate Immune Evasion of SARS-Coronavirus 2 via 2'-O-Methylation of Viral RNA.

Encinar JA and 1 other. Viruses, 2020. Cited by 78 papers, by iCite.

Cite this record

ConductScience Library. Potential Drugs Targeting Early Innate Immune Evasion of SARS-Coronavirus 2 via 2'-O-Methylation of Viral RNA. Papers, record 32397643. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/32397643

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Potential Drugs Targeting Early Innate Immune Evasion of SARS-Coronavirus 2 via 2'-O-Methylation of Viral RNA.
PubMed
Journal
Viruses
PubMed
Year
2020
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
78
iCite
Relative citation ratio, by iCite
4.05
iCite
Revised in PubMed
2024-07-30
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Encinar JAJosé Antoniohttps://orcid.org/0000-0002-7219-3863
2Menendez JAJavier Ahttps://orcid.org/0000-0001-8733-4561

Source PubMed

Download CSV of authors

Topics15

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
BetacoronavirusMajor topic
Coronavirus InfectionsMajor topic
Immune EvasionMajor topic
Pneumonia, ViralMajor topic
RNA Processing, Post-TranscriptionalMajor topic
RNA, ViralMajor topic
COVID-19
Drug Repositioning
Humans
Immunity, Innate
Methylation
Models, Molecular
Pandemics
SARS-CoV-2
COVID-19 Drug Treatment

Source PubMed

Download CSV of topics

Grants3

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
SAF2016-80639-PMinisterio de Ciencia e InnovaciónInternationalPubMed
AGL2015-67995-C3-R-1-RMinisterio de Economía, Industria y Competitividad, Gobierno de EspañaInternationalPubMed
PROMETEO/2016/006Generalitat ValencianaInternationalPubMed

Source PubMed

Download CSV of grants

References160

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
124121756Antiviral activity, pharmacokinetics, and safety of the HIV-1 protease inhibitor TMC310911, coadministered with ritonavir, in treatment-naive HIV-1-infected patients.J Acquir Immune Defic Syndr2014https://conductscience.org/library/papers/24121756PubMed
227510546Calculating protein-ligand binding affinities with MMPBSA: Method and error analysis.J Comput Chem2016https://conductscience.org/library/papers/27510546PubMed
330866804CGRP and migraine from a cardiovascular point of view: what do we expect from blocking CGRP?J Headache Pain2019https://conductscience.org/library/papers/30866804PubMed
432217835Clinical and immunological features of severe and moderate coronavirus disease 2019.J Clin Invest2020https://conductscience.org/library/papers/32217835PubMed
526036224In vitro combinations containing Tegobuvir are highly efficient in curing cells from HCV replicon and in delaying/preventing the development of drug resistance.Antiviral Res2015https://conductscience.org/library/papers/26036224PubMed
627845890Virus inactivation under the photodynamic effect of phthalocyanine zinc(II) complexes.Z Naturforsch C J Biosci2017https://conductscience.org/library/papers/27845890PubMed
723115556Brain neuropeptides in central ventilatory and cardiovascular regulation in trout.Front Endocrinol (Lausanne)2012https://conductscience.org/library/papers/23115556PubMed
830879200Understanding CGRP and Cardiovascular Risk.Handb Exp Pharmacol2019https://conductscience.org/library/papers/30879200PubMed
926769332A randomized, double-blind, placebo-controlled, dose-escalation study of the safety and efficacy of INCB039110, an oral janus kinase 1 inhibitor, in patients with stable, chronic plaque psoriasis.J Dermatolog Treat2016https://conductscience.org/library/papers/26769332PubMed
1032104915The neuroinvasive potential of SARS-CoV2 may play a role in the respiratory failure of COVID-19 patients.J Med Virol2020https://conductscience.org/library/papers/32104915PubMed
1129681484Design, synthesis, and structure-activity relationships of novel imidazo[4,5-c]pyridine derivatives as potent non-nucleoside inhibitors of hepatitis C virus NS5B.Bioorg Med Chem2018https://conductscience.org/library/papers/29681484PubMed
1221666860Discovery of PF-04457845: A Highly Potent, Orally Bioavailable, and Selective Urea FAAH Inhibitor.ACS Med Chem Lett2011https://conductscience.org/library/papers/21666860PubMed
13212459002 methylate or not 2 methylate: viral evasion of the type I interferon response.Nat Immunol2011https://conductscience.org/library/papers/21245900PubMed
1432292689Analysis of therapeutic targets for SARS-CoV-2 and discovery of potential drugs by computational methods.Acta Pharm Sin B2020https://conductscience.org/library/papers/32292689PubMed
1530546014Lysosomotropic drugs activate TFEB via lysosomal membrane fluidization and consequent inhibition of mTORC1 activity.Cell Death Dis2018https://conductscience.org/library/papers/30546014PubMed
1628183697Safety and Antitumor Activity of the Multitargeted Pan-TRK, ROS1, and ALK Inhibitor Entrectinib: Combined Results from Two Phase I Trials (ALKA-372-001 and STARTRK-1).Cancer Discov2017https://conductscience.org/library/papers/28183697PubMed
1730806710Janus kinases to jakinibs: from basic insights to clinical practice.Rheumatology (Oxford)2019https://conductscience.org/library/papers/30806710PubMed
1832196083COVID-19: a recommendation to examine the effect of hydroxychloroquine in preventing infection and progression.J Antimicrob Chemother2020https://conductscience.org/library/papers/32196083PubMed
1931995857Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus-Infected Pneumonia.N Engl J Med2020https://conductscience.org/library/papers/31995857PubMed
2031821750Evaluation of Clinical Cardiac Safety of Itacitinib, a JAK1 Inhibitor, in Healthy Participants.Clin Pharmacol Drug Dev2020https://conductscience.org/library/papers/31821750PubMed

See all 160 referencesDownload CSV of references

Cited by66

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 78 citations.

PMIDTitleJournalYearIn PapersSource
41550643Assay development and screening of inhibitors targeting the SARS-CoV-2 2'-O-methyltransferase NSP16.Pharm Sci Adv2025https://conductscience.org/library/papers/41550643PubMed
41286599OMetaNet: an efficient hybrid deep learning model based on multimodal data fusion and contrastive learning for predicting 2'-O-methylation sites in human RNA.BMC Bioinformatics2025https://conductscience.org/library/papers/41286599PubMed
40969755Immuno-epigenetic paradigms in coronavirus infection.Front Immunol2025https://conductscience.org/library/papers/40969755PubMed
40697650Epitranscriptomic Modulation of TET2 Inhibition Suppressed SARS-CoV-2 Infection and Blocked Viral Nucleocapsid Protein in Induced-Pluripotent-Stem-Cell-Derived Cardiomyocyte Screening Models.Biomater Res2025https://conductscience.org/library/papers/40697650PubMed
40291443In silico drug repurposing of potential antiviral inhibitors targeting methyltransferase (2'-O-MTase) domain of Marburg virus.In Silico Pharmacol2025https://conductscience.org/library/papers/40291443PubMed
40206865The detection, function, and therapeutic potential of RNA 2'-O-methylation.Innov Life2025https://conductscience.org/library/papers/40206865PubMed
39553294Can the use of iron phthalocyanine-derivative mouthrinses in COVID-19 patients provide systemic benefits? Research into this potential should be considered.GMS Hyg Infect Control2024https://conductscience.org/library/papers/39553294PubMed
39155972In silico analysis of balsaminol as anti-viral agents targeting SARS-CoV-2 main protease, spike receptor binding domain and papain-like protease receptors.In Silico Pharmacol2024https://conductscience.org/library/papers/39155972PubMed
38969340Structural and functional insights into the 2'-O-methyltransferase of SARS-CoV-2.Virol Sin2024https://conductscience.org/library/papers/38969340PubMed
38924058Meta-2OM: A multi-classifier meta-model for the accurate prediction of RNA 2'-O-methylation sites in human RNA.PLoS One2024https://conductscience.org/library/papers/38924058PubMed
38675143Characterization of Plant-Derived Natural Inhibitors of Dipeptidyl Peptidase-4 as Potential Antidiabetic Agents: A Computational Study.Pharmaceutics2024https://conductscience.org/library/papers/38675143PubMed
38402266Kinetic characterization of human mRNA guanine-N7 methyltransferase.Sci Rep2024https://conductscience.org/library/papers/38402266PubMed
38400997Epigenetic modulation of myeloid cell functions in HIV and SARS-CoV-2 infection.Mol Biol Rep2024https://conductscience.org/library/papers/38400997PubMed
38035086The role of post-transcriptional regulation in SARS-CoV-2 infection and pathogenicity.Front Immunol2023https://conductscience.org/library/papers/38035086PubMed
36949176Bioinformatics-based investigation on the genetic influence between SARS-CoV-2 infections and idiopathic pulmonary fibrosis (IPF) diseases, and drug repurposing.Sci Rep2023https://conductscience.org/library/papers/36949176PubMed
36913345Identification of host genomic biomarkers from multiple transcriptomics datasets for diagnosis and therapies of SARS-CoV-2 infections.PLoS One2023https://conductscience.org/library/papers/36913345PubMed
36911232Population-based virucidal phthalocyanine gargling/rinsing protocol to reduce the risk of coronavirus disease-2019: a community trial.GMS Hyg Infect Control2022https://conductscience.org/library/papers/36911232PubMed
36858323Insight into the mechanisms of coronaviruses evading host innate immunity.Biochim Biophys Acta Mol Basis Dis2023https://conductscience.org/library/papers/36858323PubMed
36551587Silibinin Overcomes EMT-Driven Lung Cancer Resistance to New-Generation ALK Inhibitors.Cancers (Basel)2022https://conductscience.org/library/papers/36551587PubMed
36366355Global Dynamics of SARS-CoV-2 Infection with Antibody Response and the Impact of Impulsive Drug Therapy.Vaccines (Basel)2022https://conductscience.org/library/papers/36366355PubMed

See all 66 cited byDownload CSV of cited by

Genes22

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
ACE259272PubTator's text mininghttps://conductscience.org/library/genes/59272NCBI Gene
ALK238PubTator's text mininghttps://conductscience.org/library/genes/238NCBI Gene
AXL558PubTator's text mininghttps://conductscience.org/library/genes/558NCBI Gene
CD4920PubTator's text mininghttps://conductscience.org/library/genes/920NCBI Gene
CD8A925PubTator's text mininghttps://conductscience.org/library/genes/925NCBI Gene
EGFR1956PubTator's text mininghttps://conductscience.org/library/genes/1956NCBI Gene
FAAH2166PubTator's text mininghttps://conductscience.org/library/genes/2166NCBI Gene
IL63569PubTator's text mininghttps://conductscience.org/library/genes/3569NCBI Gene
JAK13716PubTator's text mininghttps://conductscience.org/library/genes/3716NCBI Gene
JAK23717PubTator's text mininghttps://conductscience.org/library/genes/3717NCBI Gene
JAK33718PubTator's text mininghttps://conductscience.org/library/genes/3718NCBI Gene
KDR3791PubTator's text mininghttps://conductscience.org/library/genes/3791NCBI Gene
MTOR2475PubTator's text mininghttps://conductscience.org/library/genes/2475NCBI Gene
ROS16098PubTator's text mininghttps://conductscience.org/library/genes/6098NCBI Gene
S100A126283PubTator's text mininghttps://conductscience.org/library/genes/6283NCBI Gene
SMO6608PubTator's text mininghttps://conductscience.org/library/genes/6608NCBI Gene
SPECC192521PubTator's text mininghttps://conductscience.org/library/genes/92521NCBI Gene
STAT36774PubTator's text mininghttps://conductscience.org/library/genes/6774NCBI Gene
TXK7294PubTator's text mininghttps://conductscience.org/library/genes/7294NCBI Gene
TYK27297PubTator's text mininghttps://conductscience.org/library/genes/7297NCBI Gene

See all 22 genesDownload CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/32397643

GET https://conductscience.org/api/papers/v1/32397643/references?page=2